Affordable Care Act, Food and Drug Administration (FDA), Medicare

Health Care Week in Review: Biden Administration Announces $100 Million for ACA Marketplace Navigators and $81.3 Million for...

Alston & Bird on 9/3/2024

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

FDA Seeks to Increase Regulatory Oversight of Laboratory Developed Tests

ArentFox Schiff on 10/25/2023

On October 3, the US Food and Drug Administration (FDA) issued a proposed rule regarding the regulation of in vitro diagnostic products (IVDs). In this proposed rule, the FDA announced its intent to amend its regulations to...more

CMS Issues IPPS and LTCH PPS Final Rule for FY 2024

King & Spalding on 8/9/2023

On August 1, 2023, CMS issued its annual Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) Final Rule for FY 2024 (the Final Rule). In the Final Rule, CMS,...more

Prenatal Vaccines in Medicaid and CHIP: Coverage, Reimbursement, and State Policy Solutions to Increase Access

Manatt, Phelps & Phillips, LLP on 5/17/2023

Prenatal vaccines—those administered during a pregnancy—provide crucial protections to pregnant women and/or newborns against communicable diseases such as whooping cough and influenza. Additional prenatal vaccines are in...more

President Biden’s Budget Invests in Healthcare

McGuireWoods Consulting on 3/14/2023

Although President Biden’s budget is almost always dead on arrival on Capitol Hill, it serves as an outline of the administration’s priorities. In the budget process, the House and Senate are to work separately on budget...more

Health Care Week in Review: CMMI Announces Three New Models, President Biden Issues Executive Order

Alston & Bird on 2/20/2023

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

Health Care Week in Review: CMS Issues Prior Authorization Proposed Rule

Alston & Bird on 12/12/2022

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

Washington Healthcare Update - October 2021 #2

McGuireWoods Consulting on 10/12/2021

This week in Washington: Reconciliation delayed; short-term debt ceiling fix passed....more

Washington Healthcare Update - April 2021 #3

McGuireWoods Consulting on 4/27/2021

This week in Washington: Andrea Palm’s nomination for HHS Deputy Secretary Advances out of Senate Finance Committee, Chiquita Brooks-LaSure’s nomination deadlocked....more

Alston & Bird Health Care Week in Review - March 2021 #4

Alston & Bird on 3/29/2021

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

The Courts and Healthcare Policy

McGuireWoods Consulting on 2/2/2021

2020 saw the courts continuing to play an important role in health policy with several notable lawsuits related to the Affordable Care Act (ACA). Several other Trump administration policies were challenged, including Medicare...more

He Actually Did It: Trump Administration Implements Medicare Part B “Most Favored Nation” Drug Pricing Reform

King & Spalding on 11/24/2020

On November 20, 2020, 60 days before the end of his Administration, President Trump announced a series of major drug pricing regulations. This Alert summarizes the Most Favored Nation Model (“MFN Model”) for Medicare Part B...more

[Webinar] Looking ahead to 2021: Impacts of the election for the life sciences and health care industry - November 19th, 12:30 pm...

Hogan Lovells on 11/9/2020

Life Sciences and Health Care Horizons virtual event series - The fast pace of innovation in the life sciences and health care industry has reached an all-time high in 2020 as the industry grapples with the new reality of...more

FDA Publishes Enforcement Policies to Address Coronavirus Personal Protective Equipment Shortages

Foley & Lardner LLP on 4/7/2020

In the wake of the COVID-19 pandemic, the FDA has sought to expand the availability of needed personal protective equipment (PPE) for the general public and healthcare professionals. Recently, for example, FDA published two...more

Legal Developments to Keep an Eye Out for in 2020

Goodwin on 1/6/2020

Here are our picks of some legal developments to keep an eye out for in the new year: Federal Circuit Decisions on Bevacizumab and Trastuzumab Preliminary Injunctions: Appeals are pending on the District of Delaware’s...more

Alston & Bird Healthcare Week in Review

Alston & Bird on 11/11/2019

Below is Alston & Bird’s Healthcare Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

Healthcare Law Update: October 2019

Holland & Knight LLP on 10/15/2019

In recent years, the healthcare industry has been turning greater attention to the need to engage or involve patients in developing new technologies and systems to improve healthcare delivery. These patient engagement...more

Drug Pricing and Surprise Billing: Recent Actions and Outlook

Akin Gump Strauss Hauer & Feld LLP on 8/8/2019

Recent months have seen a flurry of activity in Congress on prescription drug pricing and surprise medical bills as lawmakers seek to address rising consumer health care costs. Several House and Senate committees have...more

Washington Healthcare Update May 2019 #2

McGuireWoods Consulting on 5/14/2019

This week in Washington: House to hold hearings on PFAS contamination and exposure, the maternal mortality crisis and single-payer issues....more

Capitol Hill Healthcare Update

BakerHostetler on 3/25/2019

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. GOTTLIEB, HARGAN TO TESTIFY ON 2020 HEALTH BUDGET, PROGRAMS - Outgoing FDA Commissioner Scott Gottlieb and...more

President Trump's Budget: Key Takeaways for Health Care

Baker Donelson on 3/18/2019

President Trump's fiscal year 2020 (FY20) budget proposal for the Department of Health and Human Services (HHS) reflects the Trump Administration's priorities to repeal and replace the Affordable Care Act (ACA), implement...more

Washington Healthcare Update March 2019 #1

McGuireWoods Consulting on 3/5/2019

Upcoming Hearings - Tuesday, March 5, 2019 - Senate Committee on Health, Education, Labor and Pensions (HELP): “Vaccines Save Lives: What is Driving Preventable Disease Outbreaks?” - The Senate Committee on Health,...more

Capitol Hill Healthcare Update

BakerHostetler on 3/4/2019

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: PBMs next in Senate committee’s crosshairs; lawmakers continue scrutiny on insulin prices;...more

Washington Healthcare Update February 2019 #2

McGuireWoods Consulting on 2/12/2019

Coming Week’s Highlights: This week’s focus by many will be whether the government shuts down once more. Legislation must be passed and signed by the President by February 15, in order to keep the departments not yet funded...more

Capitol Hill Healthcare Update

BakerHostetler on 2/5/2019

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Trump will discuss healthcare and drug costs in this week’s State of the Union address;...more

Patient Protection and Affordable Care Act (PPACA) › Food and Drug Administration (FDA) › Medicare

"My best business intelligence, in one easy email…"